These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 12506174

  • 1. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma--a report from the Intergroup Rhabdomyosarcoma Study IV.
    Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN, Crist WM.
    J Clin Oncol; 2003 Jan 01; 21(1):78-84. PubMed ID: 12506174
    [Abstract] [Full Text] [Related]

  • 2. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS.
    J Clin Oncol; 2001 Jun 15; 19(12):3091-102. PubMed ID: 11408506
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036
    [Abstract] [Full Text] [Related]

  • 4. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
    Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB.
    J Pediatr Hematol Oncol; 2001 May 20; 23(4):225-33. PubMed ID: 11846301
    [Abstract] [Full Text] [Related]

  • 5. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
    Baker KS, Anderson JR, Link MP, Grier HE, Qualman SJ, Maurer HM, Breneman JC, Wiener ES, Crist WM.
    J Clin Oncol; 2000 Jun 20; 18(12):2427-34. PubMed ID: 10856103
    [Abstract] [Full Text] [Related]

  • 6. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R.
    J Clin Oncol; 1995 Mar 20; 13(3):610-30. PubMed ID: 7884423
    [Abstract] [Full Text] [Related]

  • 7. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
    Arndt CA, Hawkins DS, Meyer WH, Sencer SF, Neglia JP, Anderson JR.
    Pediatr Blood Cancer; 2008 Jan 20; 50(1):33-6. PubMed ID: 17091486
    [Abstract] [Full Text] [Related]

  • 8. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS, Anderson JR, Paidas CN, Wharam MD, Qualman SJ, Pappo AS, Scott Baker K, Crist WM.
    J Clin Oncol; 2001 Jun 15; 19(12):3073-9. PubMed ID: 11408504
    [Abstract] [Full Text] [Related]

  • 9. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Soft Tissue Sarcoma Committee of the Children's Oncology GroupDuke University Medical Center, Durham, NC 27710, USA., Lager JJ, Lyden ER, Anderson JR, Pappo AS, Meyer WH, Breitfeld PP.
    J Clin Oncol; 2006 Jul 20; 24(21):3415-22. PubMed ID: 16849756
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML, Andrassy RJ, Raney RB, Anderson JR, Wiener ES, Rodeberg DA, Paidas CN, Lobe TE, Crist WM, Intergroup Rhabdomyosarcoma Studies I through IV.
    J Pediatr Surg; 2003 Mar 20; 38(3):347-53. PubMed ID: 12632347
    [Abstract] [Full Text] [Related]

  • 11. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, Wiener ES, Maurer HM, Crist WM.
    J Pediatr Hematol Oncol; 2001 May 20; 23(4):215-20. PubMed ID: 11846299
    [Abstract] [Full Text] [Related]

  • 12. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD, Wiener ES, Qualman SJ, Donaldson SS.
    J Clin Oncol; 1999 Nov 20; 17(11):3468-75. PubMed ID: 10550144
    [Abstract] [Full Text] [Related]

  • 13. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS, Meza JL, Donaldson SS, Wharam MD, Wiener ES, Qualman SJ, Maurer HM, Crist WM.
    J Clin Oncol; 2003 Feb 15; 21(4):638-45. PubMed ID: 12586800
    [Abstract] [Full Text] [Related]

  • 14. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R, Stevens M.
    J Clin Oncol; 2004 Dec 01; 22(23):4787-94. PubMed ID: 15570080
    [Abstract] [Full Text] [Related]

  • 15. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
    Smith LM, Anderson JR, Qualman SJ, Crist WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS.
    J Clin Oncol; 2001 Oct 15; 19(20):4058-64. PubMed ID: 11600608
    [Abstract] [Full Text] [Related]

  • 16. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Viswanathan AN, Grier HE, Litman HJ, Perez-Atayde A, Tarbell NJ, Neuberg D, Shamberger RC, Marcus KJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1208-14. PubMed ID: 15001265
    [Abstract] [Full Text] [Related]

  • 17. The Intergroup Rhabdomyosarcoma Study-II.
    Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J.
    Cancer; 1993 Mar 01; 71(5):1904-22. PubMed ID: 8448756
    [Abstract] [Full Text] [Related]

  • 18. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N, Duan C, Jin M, Zhang DW, Su Y, Yu T, He LJ, Fu LB, Zeng Q, Wang HM, Zhang WP, Ni X, Ma XL.
    Zhonghua Er Ke Za Zhi; 2019 Oct 02; 57(10):767-773. PubMed ID: 31594063
    [Abstract] [Full Text] [Related]

  • 19. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
    Raney B, Anderson J, Breneman J, Donaldson SS, Huh W, Maurer H, Michalski J, Qualman S, Ullrich F, Wharam M, Meyer W, Soft-Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California, USA.
    Pediatr Blood Cancer; 2008 Jul 02; 51(1):17-22. PubMed ID: 18266224
    [Abstract] [Full Text] [Related]

  • 20. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.
    Crist WM, Garnsey L, Beltangady MS, Gehan E, Ruymann F, Webber B, Hays DM, Wharam M, Maurer HM.
    J Clin Oncol; 1990 Mar 02; 8(3):443-52. PubMed ID: 2407808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.